Efficacy and Safety of Tislelizumab Combined with Lenvatinib and FOLFOX4-HAIC in Conversion Therapy of Middle-Advanced Stage Hepatocellular Carcinoma (HCC): A Real-World Retrospective Study
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要